NCT07323966 Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients
| NCT ID | NCT07323966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Brain Tumor |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-11-18 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-11-18 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the technical feasibility of brain radiotherapy without immobilization masks using surface imaging to ensure accurate patient positioning and continuous motion monitoring.
Eligibility Criteria
Inclusion Criteria: * Age \>= 18 years old * Brain tumor treated with fractionated radiotherapy * Able to read and complete a questionnaire in French Exclusion Criteria: * Inability to remain still
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07323966 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07323966 currently recruiting?
Yes, NCT07323966 is actively recruiting participants. Contact the research team at dario.diperri@saintluc.uclouvain.be for enrollment information.
Where is the NCT07323966 trial being conducted?
This trial is being conducted at Woluwe-Saint-Lambert, Belgium.
Who is sponsoring the NCT07323966 clinical trial?
NCT07323966 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 20 participants.